Clinical Trials Directory

Trials / Unknown

UnknownNCT02921451

Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Michigan Institution of Women's Health PC · Academic / Other
Sex
Female
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the long term performance of Restorelle system for the treatment of uterine prolapse.

Detailed description

This study is being done to evaluate the performance of the Restorelle system, which uses Smartmesh - an ultra-lightweight mesh for uterine prolapse management. Most patients undergo a hysterectomy i.e. removal of the uterus when they have a prolapse. However, this has often been found to be an unnecessary operation. The investigators are studying the use of the Restorelle mesh system to preserve the uterus when there is a uterine prolapse.

Conditions

Interventions

TypeNameDescription
DEVICERestorelle SmartmeshPatients will have surgery using the device, Restorelle Smartmesh, for treatment of uterine prolapse.

Timeline

Start date
2016-08-01
Primary completion
2020-08-01
Completion
2020-08-01
First posted
2016-10-03
Last updated
2019-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02921451. Inclusion in this directory is not an endorsement.

Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse (NCT02921451) · Clinical Trials Directory